**Inpatient Discharge Summary**

**Patient Name:** [B-NAME]Harold Thompson[O]  
**MRN:** [B-ID]998432156[O]  
**Age:** [B-AGE]65 years old[O]  
**Admission Date:** [B-DATE]September 5, 2023[O]  
**Discharge Date:** [B-DATE]September 19, 2023[O]  
**Attending Physician:** Dr. [B-NAME]Anna Patel[O]  
**Service:** Cardiology 

**Hospital Course:**  
Mr. [B-NAME]Thompson[O] was admitted for management of acute congestive heart failure and atrial fibrillation. Initial ECG on admission showed atrial fibrillation with a rapid ventricular response. He was started on IV diuretics and beta-blockers to control his heart rate. His congestive heart failure symptoms improved with diuretics, as evidenced by reduced lower extremity edema and improved dyspnea.

[B-DATE]September 7, 2023[O]: Cardiology consult recommended starting [B-NAME]Thompson[O] on anticoagulation therapy given his CHA₂DS₂-VASc score of 3.

[B-DATE]September 12, 2023[O]: Mr. [B-NAME]Thompson[O] underwent successful electrical cardioversion, returning his rhythm to sinus. He remained hemodynamically stable throughout his stay with improvement in heart function noted on follow-up echocardiogram before discharge.

**Medications at Discharge:**
- Apixaban 5 mg twice daily
- Metoprolol Tartrate 50 mg twice daily
- Furosemide 40 mg daily
- Potassium Chloride 20 mEq daily

**Follow-up Instructions:**
- Cardiology follow-up with Dr. [B-NAME]Elijah Lee[O] on [B-DATE]October 3, 2023[O].
- Primary care follow-up within one week post-discharge to reassess blood pressure and kidney function.
- Continue weight monitoring and adhere to a low-salt diet.

**Discharge Disposition:**
Mr. [B-NAME]Thompson[O] is discharged to his home under the care of his daughter, [B-NAME]Emily Thompson[O]. He was counseled on the importance of adhering to his new medication regimen and monitoring his daily weights. His functional capacity has improved, and he should progressively increase his activity as tolerated.

**Discharge Condition:**
Mr. [B-NAME]Thompson[O]'s condition is stable with improvement noted in cardiac function and symptom control. He will continue outpatient management for his heart condition.

**Readmission Risk:**
Assessed as moderate given the recent hospitalization and nature of cardiac conditions.

**Pending Lab Results:**
- Thyroid Function Tests sent [B-DATE]September 18, 2023[O].

**Signature:**  
Dr. [B-NAME]Anna Patel[O], MD  
[B-DATE]September 19, 2023[O]

**Hospital:** [B-ORGANIZATION]Saint Luke's Medical Center[O]
